Isotretinoin and teratogenicity. 1988

J S Strauss, and W J Cunningham, and J J Leyden, and P E Pochi, and A R Shalita

UI MeSH Term Description Entries
D003267 Contraception Prevention of CONCEPTION by blocking fertility temporarily, or permanently (STERILIZATION, REPRODUCTIVE). Common means of reversible contraception include NATURAL FAMILY PLANNING METHODS; CONTRACEPTIVE AGENTS; or CONTRACEPTIVE DEVICES. Birth Control,Contraceptive Methods,Female Contraception,Fertility Control,Inhibition of Fertilization,Male Contraception,Contraception, Female,Contraception, Male,Contraceptions, Female,Contraceptions, Male,Contraceptive Method,Female Contraceptions,Fertilization Inhibition,Male Contraceptions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000014 Abnormalities, Drug-Induced Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment. Drug-Induced Abnormalities,Abnormalities, Drug Induced,Abnormality, Drug-Induced,Drug Induced Abnormalities,Drug-Induced Abnormality
D013723 Teratogens An agent that causes the production of physical defects in the developing embryo. Embryotoxins,Fetotoxins,Teratogen
D015474 Isotretinoin A topical dermatologic agent that is used in the treatment of ACNE VULGARIS and several other skin diseases. The drug has teratogenic and other adverse effects. 13-cis-Retinoic Acid,Accutane,Isotretinoin Zinc Salt, 13-cis-Isomer,Ro 4-3780,Roaccutane,13 cis Retinoic Acid,Isotretinoin Zinc Salt, 13 cis Isomer,Ro 4 3780,Ro 43780

Related Publications

J S Strauss, and W J Cunningham, and J J Leyden, and P E Pochi, and A R Shalita
June 1984, Lancet (London, England),
J S Strauss, and W J Cunningham, and J J Leyden, and P E Pochi, and A R Shalita
August 1988, Lancet (London, England),
J S Strauss, and W J Cunningham, and J J Leyden, and P E Pochi, and A R Shalita
March 1988, Lancet (London, England),
J S Strauss, and W J Cunningham, and J J Leyden, and P E Pochi, and A R Shalita
January 1988, Lancet (London, England),
J S Strauss, and W J Cunningham, and J J Leyden, and P E Pochi, and A R Shalita
November 1987, Lancet (London, England),
J S Strauss, and W J Cunningham, and J J Leyden, and P E Pochi, and A R Shalita
September 1986, Nutrition reviews,
J S Strauss, and W J Cunningham, and J J Leyden, and P E Pochi, and A R Shalita
September 1998, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
J S Strauss, and W J Cunningham, and J J Leyden, and P E Pochi, and A R Shalita
November 1988, Lancet (London, England),
J S Strauss, and W J Cunningham, and J J Leyden, and P E Pochi, and A R Shalita
October 1984, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
J S Strauss, and W J Cunningham, and J J Leyden, and P E Pochi, and A R Shalita
August 1983, Lancet (London, England),
Copied contents to your clipboard!